| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050153410 |
| P356 | DOI | 10.1023/B:MEBR.0000043982.17294.9B |
| P698 | PubMed publication ID | 15554428 |
| P50 | author | Patrice Cacoub | Q42226825 |
| P2093 | author name string | Nicolas Limal | |
| Damien Sène | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| Cryoglobulins | Q24673191 | ||
| Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence | Q67852517 | ||
| Cryoglobulinaemia and hepatitis C infection | Q68322890 | ||
| Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. A prospective study on 20 patients | Q71406534 | ||
| Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda | Q71698209 | ||
| Clinical and virological findings in mixed cryoglobulinaemia | Q71943031 | ||
| Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice | Q72622693 | ||
| Hepatitis C in patients with porphyria cutanea tarda | Q72810934 | ||
| Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II | Q73053045 | ||
| Is diabetes mellitus a risk factor for HCV infection? | Q73130350 | ||
| The Porphyrias | Q73237076 | ||
| HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France | Q73646374 | ||
| Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C | Q73664671 | ||
| Mixed cryoglobulins and autoimmunity in hepatitis C | Q73694295 | ||
| Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia | Q74052572 | ||
| Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients | Q74613538 | ||
| Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis | Q74835670 | ||
| Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study | Q77866801 | ||
| [Peripheral nervous system involvement in HCV-related mixed cryoglobulinemia] | Q78599855 | ||
| Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20 | Q78728686 | ||
| Increased frequency of HCV and HBV infection in type 2 diabetic patients | Q93934003 | ||
| Hepatitis C virus infection in non-Hodgkin‘s lymphoma | Q42989261 | ||
| Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? | Q42989441 | ||
| Porphyria cutanea tarda and hepatitis G and C virus infection | Q42990248 | ||
| Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture | Q42991870 | ||
| Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infection | Q42992723 | ||
| Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia | Q42994975 | ||
| Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection | Q42995347 | ||
| Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection | Q42995461 | ||
| Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus | Q42998123 | ||
| Hepatitis C virus risk: a hepatitis C virus related syndrome | Q42998596 | ||
| Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process | Q42999023 | ||
| Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma | Q43029933 | ||
| Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection | Q43030035 | ||
| Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study | Q43033800 | ||
| Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection | Q43035387 | ||
| Mixed cryoglobulinemia and hepatitis C virus | Q43035467 | ||
| Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. | Q43035673 | ||
| Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations. | Q43035982 | ||
| Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study | Q43036300 | ||
| A comprehensive study of the association between hepatitis C virus and glomerulopathy | Q43036374 | ||
| High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. | Q43037020 | ||
| Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany | Q43037028 | ||
| Detection of hepatitis C virus by polymerase chain reaction and recombinant immunoblot assay 3.0 in porphyria cutanea tarda | Q43037033 | ||
| Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT). | Q43037308 | ||
| Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia | Q43037362 | ||
| Porphyria cutanea tarda and antibodies to hepatitis C virus. | Q43038650 | ||
| Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection | Q43038794 | ||
| HCV infection in porphyria cutanea tarda | Q43038848 | ||
| Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis | Q43039778 | ||
| Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis | Q43040181 | ||
| Hepatitis C virus infection in patients with non-Hodgkin's lymphoma | Q43040331 | ||
| Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy | Q43040667 | ||
| Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis | Q43041401 | ||
| Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy | Q43041667 | ||
| Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection | Q43042179 | ||
| High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders. | Q43047190 | ||
| Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency | Q43047381 | ||
| Cryoglobulinemia with vasculitis associated with hepatitis C virus infection | Q43048486 | ||
| Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus | Q43048623 | ||
| Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus | Q43049410 | ||
| Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa | Q43049504 | ||
| Motor-axonal polyneuropathy associated with hepatitis C virus | Q43049538 | ||
| Porphyria cutanea tarda and hepatitis C virus infection | Q43520693 | ||
| Fatigue in patients with chronic hepatitis C. | Q43549742 | ||
| C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients | Q43703709 | ||
| Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia. | Q44100312 | ||
| Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II mixed cryoglobulinemia associated with HCV infection | Q44275829 | ||
| Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation | Q44399985 | ||
| Association between hepatitis C, diabetes mellitus, and race. a case-control study | Q44406442 | ||
| Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicentric study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC) | Q44451023 | ||
| Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. | Q44471012 | ||
| Porphyria cutanea tarda and hepatitis C virus infection. Clinical and virological study | Q44477477 | ||
| Characterization of cryoglobulins by immunoblotting | Q44533676 | ||
| Diagnostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa | Q44793940 | ||
| Polyarteritis nodosa and hepatitis C virus infection | Q44805249 | ||
| Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. | Q44813341 | ||
| Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection | Q44932526 | ||
| Cryoglobulinaemia and serological markers of hepatitis viruses. | Q44935920 | ||
| Effect of 51p1-related gene copy number (V1-69 locus) on production of hepatitis C-associated cryoglobulins | Q44990800 | ||
| Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. | Q45265184 | ||
| Extrahepatic manifestations of hepatitis C among United States male veterans | Q45333951 | ||
| Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency | Q45713240 | ||
| Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon | Q45722270 | ||
| Hepatitis C: a possible etiology for cryoglobulinaemia type II | Q27473549 | ||
| Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia | Q27477870 | ||
| Prevalence and clinical features of cryoglobulinaemia in multitransfused beta-thalassaemia patients | Q27477924 | ||
| Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia | Q27480545 | ||
| Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes | Q27480916 | ||
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| Hepatitis C virus infection | Q27861002 | ||
| Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide | Q28245218 | ||
| Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis | Q33329475 | ||
| Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. | Q33331448 | ||
| Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: role of thrombopoietin | Q33335312 | ||
| Interferon treatment for thrombocytopenia associated with chronic HCV infection. | Q33336172 | ||
| Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma. | Q33338804 | ||
| Treatment of hepatitis C related thrombocytopenia with interferon alpha | Q33340288 | ||
| Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis | Q33344948 | ||
| Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome | Q33346556 | ||
| Hepatitis C virus infection and autoimmune thrombocytopenic purpura | Q33496566 | ||
| Thrombocytopenia associated with hepatitis C viral infection | Q33497636 | ||
| Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group | Q33500894 | ||
| Autoimmune Thrombocytopenia Associated with Hepatitis C Virus Infection | Q33502899 | ||
| Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? | Q33735350 | ||
| Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. | Q33873031 | ||
| Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex | Q33932719 | ||
| Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection | Q34058506 | ||
| Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases | Q34154745 | ||
| Biologic and clinical significance of cryoglobulins. A report of 86 cases | Q34204386 | ||
| Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. | Q34307681 | ||
| Management of hepatitis C virus-related arthritis | Q34387501 | ||
| Small-Vessel Vasculitis | Q34445978 | ||
| Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes | Q34722742 | ||
| Kidney and liver involvement in cryoglobulinemia | Q34739938 | ||
| Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia | Q34746694 | ||
| Association of diabetes mellitus and chronic hepatitis C virus infection. | Q34756492 | ||
| The clinical and morphologic spectrum of renal cryoglobulinemia | Q34917557 | ||
| Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study | Q45723848 | ||
| Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas | Q45730654 | ||
| Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia | Q45733494 | ||
| Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study | Q45735097 | ||
| Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia | Q45735396 | ||
| Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France | Q45737062 | ||
| The role of hepatitis C virus infection in glomerulopathy | Q45739946 | ||
| Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group | Q45742402 | ||
| Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection | Q45743207 | ||
| T(14;18) translocation in chronic hepatitis C virus infection | Q45744785 | ||
| Descriptive epidemiology of non-Hodgkin lymphomas in a southwestern French hematology center: absence of significant relationship with hepatitis C virus infection | Q45744848 | ||
| Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. | Q45746740 | ||
| Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia | Q45748638 | ||
| Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course | Q45749351 | ||
| Arthritis in patients with chronic hepatitis C virus infection | Q45751329 | ||
| High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia. | Q45753179 | ||
| Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal | Q45754047 | ||
| Prevalence of Cryoglobulinemia in Chronic Hepatitis C Virus Infection and Response to Treatment With Interferon-α | Q45758150 | ||
| Hepatitis C Virus Infection in Patients with B-Cell Non-Hodgkin Lymphoma | Q45760281 | ||
| Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas | Q45761521 | ||
| High prevalence of hepatitis C virus infection in Japanese patients with porphyria cutanea tarda | Q45761957 | ||
| Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients | Q45765783 | ||
| HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders | Q45766137 | ||
| High prevalence of hepatitis C virus infection in diabetic patients | Q45767196 | ||
| Hepatitis C virus and non-Hodgkin's lymphomas | Q45768548 | ||
| Sicca syndrome associated with hepatitis C virus infection | Q45770092 | ||
| Hepatitis C virus and essential mixed cryoglobulinaemia | Q45776176 | ||
| Immunological disorders in C virus chronic active hepatitis: a prospective case-control study | Q45779172 | ||
| Is hepatitis C virus infection a trigger of porphyria cutanea tarda? | Q45787026 | ||
| Hepatitis C virus associated cryoglobulinemic neuropathy successfully treated with plasma exchange | Q45788203 | ||
| Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus | Q45788588 | ||
| Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda | Q45789957 | ||
| Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. | Q45791425 | ||
| Hepatitis C virus in patients with cryoglobulinemia type II. | Q45852251 | ||
| Association between hepatitis C virus and polyarteritis nodosa | Q45874942 | ||
| Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia | Q46650974 | ||
| Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity | Q47717788 | ||
| Neurological manifestations of chronic hepatitis C. | Q48146944 | ||
| Central Nervous System Involvement in Patients With HCV-Related Cryoglobulinemia | Q48499972 | ||
| Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose | Q48797565 | ||
| The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland | Q50986042 | ||
| Cryoglobulinemia | Q56907690 | ||
| Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy | Q58324990 | ||
| Anti-neutrophil cytoplasmic antibodies and mixed cryoglobulinemia | Q58622231 | ||
| Detection of occult low-grade B-cell non-hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia | Q61873087 | ||
| Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease | Q62607278 | ||
| Liver involvement in essential mixed cryoglobulinemia | Q67002290 | ||
| Liver involvement in the syndrome of mixed cryoglobulinemia | Q67671002 | ||
| Hepatitis B and essential mixed cryoglobulinemia | Q67678261 | ||
| Extrahepatic manifestations of hepatitis C infection | Q35086276 | ||
| Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. | Q35217843 | ||
| Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus | Q35355811 | ||
| Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection | Q35547638 | ||
| Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis | Q35552273 | ||
| Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. | Q35629704 | ||
| Glucose intolerance in Chinese patients with chronic hepatitis C. | Q36209725 | ||
| Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection | Q38501003 | ||
| Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia | Q39369828 | ||
| Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus | Q40398089 | ||
| High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. | Q40398188 | ||
| Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations | Q40483846 | ||
| Musculoskeletal manifestations and autoantibody profilein 90 hepatitis C virus infected israeli patients | Q40836416 | ||
| Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia | Q40919365 | ||
| Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment. | Q40964652 | ||
| The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. | Q41054958 | ||
| Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis | Q41212359 | ||
| High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. | Q41519138 | ||
| Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital | Q41647607 | ||
| Ascorbic acid deficiency in porphyria cutanea tarda | Q42547915 | ||
| Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. | Q42977076 | ||
| HCV genotypes and cryoglobulinemia. | Q42977916 | ||
| HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus | Q42977929 | ||
| Interferon in the treatment of mixed cryoglobulinemia. | Q42977968 | ||
| Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation | Q42978154 | ||
| Non-Hodgkin's lymphoma and hepatitis C virus infection | Q42980007 | ||
| Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia | Q42980056 | ||
| Hepatitis C virus infection in patients with essential mixed cryoglobulinemia | Q42981885 | ||
| Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. | Q42982173 | ||
| Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease | Q42982623 | ||
| Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association | Q42982870 | ||
| Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. | Q42983061 | ||
| A role for hepatitis C virus infection in type II cryoglobulinemia | Q42983385 | ||
| B cell malignancy and hepatitis C virus infection. | Q42983624 | ||
| The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association? | Q42984169 | ||
| Interferon-α treatment of hepatitis C virus-associated mixed cryoglobulinemia | Q42984188 | ||
| Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia | Q42984959 | ||
| Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. | Q42985058 | ||
| Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma: evidence for a pathogenetic role | Q42985190 | ||
| Cryoglobulinaemia and hepatitis C virus | Q42985345 | ||
| Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia | Q42986709 | ||
| Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. | Q42987134 | ||
| Hepatitis C associated with Guillain‐Barré syndrome | Q42987448 | ||
| In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype | Q42987798 | ||
| Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america† | Q42988426 | ||
| Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. | Q42988999 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 357-381 | |
| P577 | publication date | 2004-12-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Metabolic Brain Disease | Q15764352 |
| P1476 | title | Hepatitis C virus-associated extrahepatic manifestations: a review | |
| P478 | volume | 19 |
| Q33382854 | Autoimmune thrombocytopenia related to chronic hepatitis C virus infection. |
| Q46231465 | Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C. |
| Q43821191 | Comorbidity of rheumatic and hepatic diseases |
| Q41384070 | Cutaneous manifestations of viral hepatitis |
| Q26781746 | Dermatologic Extrahepatic Manifestations of Hepatitis C |
| Q37084557 | Dysmetabolic changes associated with HCV: a distinct syndrome? |
| Q36497753 | Efficacy and safety of rituximab in the treatment of vasculitic leg ulcers associated with hepatitis C virus infection. |
| Q38638550 | Evidence for association between hepatitis C virus and Parkinson's disease |
| Q39066204 | Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis |
| Q36410569 | Extrahepatic manifestations of hepatitis C virus |
| Q36519154 | Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences |
| Q37251204 | HCV synergizes with body weight in the promotion of insulin resistance |
| Q40315269 | Hepatitis C Virus-related Arthritis: Bone Scintigraphic Appearances |
| Q43457583 | Hepatitis C and cutaneous alterations |
| Q26775815 | Hepatitis C genotype 4: The past, present, and future |
| Q35574487 | Hepatitis C treatment of patients with bipolar disorder: a case series |
| Q57160237 | Hepatitis C vaccines |
| Q52661702 | Hepatitis C virus: Morphogenesis, infection and therapy |
| Q33788274 | History of blood transfusion before 1990 is associated with increased risk for cancer mortality independently of liver disease: a prospective long-term follow-up study |
| Q44707256 | Liver and rheumatism |
| Q43978963 | Local treatment of non healing leg ulcers in a patient with hepatitis C virus infection |
| Q42256023 | Measuring the response of extrahepatic symptoms and quality of life to antiviral treatment in patients with hepatitis C. |
| Q21284981 | Morphologic features of extrahepatic manifestations of hepatitis C virus infection |
| Q41823282 | Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report. |
| Q38063990 | Natural history of acute and chronic hepatitis C |
| Q37987774 | Neuromuscular Diseases Associated With Chronic Hepatitis C Virus Infection |
| Q36419286 | Oculo-renal disorders in infectious diseases |
| Q38160291 | Oral conditions associated with hepatitis C virus infection. |
| Q35201308 | Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment |
| Q36635470 | Post-transplant diabetes mellitus: risk reduction strategies in the elderly |
| Q37019765 | SASLT practice guidelines: management of hepatitis C virus infection. |
| Q34750602 | Study of pruritus in chronic hepatitis C patients |
| Q42274530 | The presence of thyroid peroxidase antibody of IgG2 subclass is a risk factor for thyroid dysfunction in chronic hepatitis C patients |
| Q38130916 | The two-edged sword: vasculitis associated with HIV and hepatitis C coinfection. |
| Q54548523 | Total joint arthroplasty in patients with chronic infectious liver disease |
| Q39343958 | Treatment of hepatitis C cryoglobulinemia: mission and challenges |
| Q80088546 | [Neuromuscular complications in transplant recipients] |
Search more.